APO Research
Talk to an analyst

APO RESEARCH · REPORT

Riociguat Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Riociguat Tablets Market Outlook and Growth Opportunities 2026

30 December 2025190 pages

Choose your research edition.

Industry ResearchRiociguat Tablets Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Riociguat Tablets Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Riociguat Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Riociguat Tablets Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Riociguat Tablets Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Riociguat Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Riociguat Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Riociguat Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Riociguat Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Riociguat Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Riociguat Tablets market include M Care Exports, MSD-UK and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Riociguat Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Riociguat Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Riociguat Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Riociguat Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Riociguat Tablets Segment by Company

M Care Exports

MSD-UK

Bayer

Riociguat Tablets Segment by Type

0.5mg

1.5mg

1mg

2.5mg

2mg

Riociguat Tablets Segment by Application

Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Pulmonary Arterial Hypertension (PAH)

Riociguat Tablets Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Riociguat Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Riociguat Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Riociguat Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Riociguat Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Riociguat Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Riociguat Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Riociguat Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Riociguat Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Riociguat Tablets industry.

Chapter 3: Detailed analysis of Riociguat Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Riociguat Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Riociguat Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Riociguat Tablets Industry Trends Table 2. Riociguat Tablets Industry Drivers Table 3. Riociguat Tablets Industry Opportunities and Challenges Table 4. Riociguat Tablets Industry Restraints Table 5. Global Riociguat Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Riociguat Tablets Revenue Share by Company (2021-2026) Table 7. Global Riociguat Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Riociguat Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Riociguat Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Riociguat Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Riociguat Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Riociguat Tablets Company, Product Type & Application Table 13. Global Riociguat Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Riociguat Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 0.5mg Table 18. Significant Companies of 1.5mg Table 19. Significant Companies of 1mg Table 20. Significant Companies of 2.5mg Table 21. Significant Companies of 2mg Table 22. Global Riociguat Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Riociguat Tablets Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Riociguat Tablets Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Riociguat Tablets Sales Volume Share by Type (2021-2026) Table 26. Global Riociguat Tablets Sales Volume Share by Type (2027-2032) Table 27. Global Riociguat Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Riociguat Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Riociguat Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Riociguat Tablets Sales Value Share by Type (2021-2026) Table 31. Global Riociguat Tablets Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Table 33. Significant Companies of Pulmonary Arterial Hypertension (PAH) Table 34. Global Riociguat Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Riociguat Tablets Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Riociguat Tablets Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Riociguat Tablets Sales Volume Share by Application (2021-2026) Table 38. Global Riociguat Tablets Sales Volume Share by Application (2027-2032) Table 39. Global Riociguat Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Riociguat Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Riociguat Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Riociguat Tablets Sales Value Share by Application (2021-2026) Table 43. Global Riociguat Tablets Sales Value Share by Application (2027-2032) Table 44. Global Riociguat Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Riociguat Tablets Sales by Region (2021-2026) & (K Units) Table 46. Global Riociguat Tablets Sales Market Share by Region (2021-2026) Table 47. Global Riociguat Tablets Sales by Region (2027-2032) & (K Units) Table 48. Global Riociguat Tablets Sales Market Share by Region (2027-2032) Table 49. Global Riociguat Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Riociguat Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Riociguat Tablets Sales Value Share by Region (2021-2026) Table 52. Global Riociguat Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Riociguat Tablets Sales Value Share by Region (2027-2032) Table 54. Global Riociguat Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Riociguat Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Riociguat Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Riociguat Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Riociguat Tablets Sales by Country (2021-2026) & (K Units) Table 59. Global Riociguat Tablets Sales Market Share by Country (2021-2026) Table 60. Global Riociguat Tablets Sales by Country (2027-2032) & (K Units) Table 61. Global Riociguat Tablets Sales Market Share by Country (2027-2032) Table 62. Global Riociguat Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Riociguat Tablets Sales Value Market Share by Country (2021-2026) Table 64. Global Riociguat Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Riociguat Tablets Sales Value Market Share by Country (2027-2032) Table 66. M Care Exports Company Information Table 67. M Care Exports Business Overview Table 68. M Care Exports Riociguat Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. M Care Exports Riociguat Tablets Product Portfolio Table 70. M Care Exports Recent Development Table 71. MSD-UK Company Information Table 72. MSD-UK Business Overview Table 73. MSD-UK Riociguat Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. MSD-UK Riociguat Tablets Product Portfolio Table 75. MSD-UK Recent Development Table 76. Bayer Company Information Table 77. Bayer Business Overview Table 78. Bayer Riociguat Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Bayer Riociguat Tablets Product Portfolio Table 80. Bayer Recent Development Table 81. Key Raw Materials Table 82. Raw Materials Key Suppliers Table 83. Riociguat Tablets Distributors List Table 84. Riociguat Tablets Customers List Table 85. Research Programs/Design for This Report Table 86. Authors List of This Report Table 87. Secondary Sources Table 88. Primary Sources List of Figures Figure 1. Riociguat Tablets Product Image Figure 2. Global Riociguat Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Riociguat Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Riociguat Tablets Sales (2021-2032) & (K Units) Figure 5. Global Riociguat Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Riociguat Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 0.5mg Image Figure 10. 1.5mg Image Figure 11. 1mg Image Figure 12. 2.5mg Image Figure 13. 2mg Image Figure 14. Global Riociguat Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Riociguat Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Riociguat Tablets Sales Volume Share by Type (2021-2032) Figure 17. Global Riociguat Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Riociguat Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Riociguat Tablets Sales Value Share by Type (2021-2032) Figure 20. Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Image Figure 21. Pulmonary Arterial Hypertension (PAH) Image Figure 22. Global Riociguat Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Riociguat Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Riociguat Tablets Sales Volume Share by Application (2021-2032) Figure 25. Global Riociguat Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Riociguat Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Riociguat Tablets Sales Value Share by Application (2021-2032) Figure 28. Global Riociguat Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Riociguat Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Riociguat Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Riociguat Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Riociguat Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. North America Riociguat Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Riociguat Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Riociguat Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Riociguat Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Riociguat Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Riociguat Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. South America Riociguat Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Riociguat Tablets Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Riociguat Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Riociguat Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Riociguat Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Riociguat Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Riociguat Tablets Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Riociguat Tablets Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5mg
  • 1.5mg
  • 1mg
  • 2.5mg
  • 2mg
Applications
  • Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
  • Pulmonary Arterial Hypertension (PAH)
Companies covered
  • M Care Exports
  • MSD-UK
  • Bayer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Riociguat Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Riociguat Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Riociguat Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Riociguat Tablets Market Dynamics
  1. 2.1 Riociguat Tablets Industry Trends
  2. 2.2 Riociguat Tablets Industry Drivers
  3. 2.3 Riociguat Tablets Industry Opportunities and Challenges
  4. 2.4 Riociguat Tablets Industry Restraints
3 Riociguat Tablets Market by Company
  1. 3.1 Global Riociguat Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Riociguat Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Riociguat Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Riociguat Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Riociguat Tablets Company Ranking (2024-2026)
  6. 3.6 Global Riociguat Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Riociguat Tablets Company Product Type and Application
  8. 3.8 Global Riociguat Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Riociguat Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Riociguat Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Riociguat Tablets Market by Type
  1. 4.1 Riociguat Tablets Type Introduction
  2. 4.1.1 0.5mg
  3. 4.1.2 1.5mg
  4. 4.1.3 1mg
  5. 4.1.4 2.5mg
  6. 4.1.5 2mg
  7. 4.2 Global Riociguat Tablets Sales Volume by Type
  8. 4.2.1 Global Riociguat Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Riociguat Tablets Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Riociguat Tablets Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Riociguat Tablets Sales Value by Type
  12. 4.3.1 Global Riociguat Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Riociguat Tablets Sales Value by Type (2021-2032)
  14. 4.3.3 Global Riociguat Tablets Sales Value Share by Type (2021-2032)
5 Riociguat Tablets Market by Application
  1. 5.1 Riociguat Tablets Application Introduction
  2. 5.1.1 Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
  3. 5.1.2 Pulmonary Arterial Hypertension (PAH)
  4. 5.2 Global Riociguat Tablets Sales Volume by Application
  5. 5.2.1 Global Riociguat Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Riociguat Tablets Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Riociguat Tablets Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Riociguat Tablets Sales Value by Application
  9. 5.3.1 Global Riociguat Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Riociguat Tablets Sales Value by Application (2021-2032)
  11. 5.3.3 Global Riociguat Tablets Sales Value Share by Application (2021-2032)
6 Riociguat Tablets Regional Sales and Value Analysis
  1. 6.1 Global Riociguat Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Riociguat Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Riociguat Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Riociguat Tablets Sales by Region (2027-2032)
  5. 6.3 Global Riociguat Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Riociguat Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Riociguat Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Riociguat Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Riociguat Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Riociguat Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Riociguat Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Riociguat Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Riociguat Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Riociguat Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Riociguat Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Riociguat Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Riociguat Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Riociguat Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Riociguat Tablets Sales Value Share by Country, 2025 VS 2032
7 Riociguat Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Riociguat Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Riociguat Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Riociguat Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Riociguat Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Riociguat Tablets Sales by Country (2027-2032)
  6. 7.4 Global Riociguat Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Riociguat Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Riociguat Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Riociguat Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Riociguat Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Riociguat Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Riociguat Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Riociguat Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Riociguat Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Riociguat Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Riociguat Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Riociguat Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Riociguat Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Riociguat Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Riociguat Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Riociguat Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Riociguat Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Riociguat Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Riociguat Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Riociguat Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Riociguat Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Riociguat Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Riociguat Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Riociguat Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Riociguat Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Riociguat Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Riociguat Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Riociguat Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Riociguat Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Riociguat Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Riociguat Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Riociguat Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Riociguat Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 M Care Exports
  2. 8.1.1 M Care Exports Company Information
  3. 8.1.2 M Care Exports Business Overview
  4. 8.1.3 M Care Exports Riociguat Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 M Care Exports Riociguat Tablets Product Portfolio
  6. 8.1.5 M Care Exports Recent Developments
  7. 8.2 MSD-UK
  8. 8.2.1 MSD-UK Company Information
  9. 8.2.2 MSD-UK Business Overview
  10. 8.2.3 MSD-UK Riociguat Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 MSD-UK Riociguat Tablets Product Portfolio
  12. 8.2.5 MSD-UK Recent Developments
  13. 8.3 Bayer
  14. 8.3.1 Bayer Company Information
  15. 8.3.2 Bayer Business Overview
  16. 8.3.3 Bayer Riociguat Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bayer Riociguat Tablets Product Portfolio
  18. 8.3.5 Bayer Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Riociguat Tablets Value Chain Analysis
  2. 9.1.1 Riociguat Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Riociguat Tablets Sales Mode & Process
  6. 9.2 Riociguat Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Riociguat Tablets Distributors
  9. 9.2.3 Riociguat Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst